Institutional Ownership Acurx Pharmaceuticals, Inc. (ACXP)
This table provides information about the institutional ownership of Acurx Pharmaceuticals, Inc. (ACXP). We have compiled data on the 29 institutions that hold shares in the stock, with a total of 3.53 Million shares, which have been reported (via 13F filing form) to have a value of $1.59 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
47
shares
|
$21
0.0% of portfolio
|
Q1 2025
Reduced 99.21%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
29
shares
|
$13
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|